OBJECTIVEdTo evaluate the insulin requirements in women with type 1 diabetes during twin pregnancy compared with singleton pregnancy. RESULTSdIn twin pregnancies, the weekly increase in daily insulin dose between 14 and 27 weeks was higher than in singleton pregnancies (median 3.0 international units [IU] [range 0.9-4.9] versus 1.5 IU [21.5 to 5.9]; P = 0.008) and remained stable from 27 to 33 weeks. The increment in total insulin requirement from before pregnancy until 33 weeks tended to be higher in twin pregnancies (103% [36-257%] versus 71% [220 to 276%]; P = 0.07). Throughout pregnancy, HbA 1c was similar in twin and singleton pregnancies.
RESULTSdIn twin pregnancies, the weekly increase in daily insulin dose between 14 and 27 weeks was higher than in singleton pregnancies (median 3.0 international units [IU] [range 0.9-4.9] versus 1.5 IU [21.5 to 5.9]; P = 0.008) and remained stable from 27 to 33 weeks. The increment in total insulin requirement from before pregnancy until 33 weeks tended to be higher in twin pregnancies (103% [36-257%] versus 71% [220 to 276%]; P = 0.07). Throughout pregnancy, HbA 1c was similar in twin and singleton pregnancies.
CONCLUSIONSdIn twin pregnancies, the weekly increase in insulin dose between 14 and 27 weeks was doubled compared with singleton pregnancies.
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B ased on clinical experience, some clinicians expect a doubling of insulin requirement in third trimester of twin pregnancies compared with singleton pregnancies in women with type 1 diabetes. As no studies have investigated the insulin requirement during twin pregnancy, we investigated this in women with type 1 diabetes during twin pregnancy compared with that in singleton pregnancies. HbA 1c ,5.6% in second part of pregnancy was recommended (1). Overall, patient management remained fairly unchanged during the study period.
RESEARCH DESIGN AND
Diabetic retinopathy was diagnosed with retinal photos at inclusion (2) .
The study was approved by the Danish Data Protection Agency. According to Danish law, the regional committees for ethics and science did not have to be contacted.
Statistical analysis
Data are given as median (range) or number (%). Differences between groups were analyzed using x 2 test or Fisher's exact test, as appropriate, for categorical variables and by Kruskal-Wallis or MannWhitney tests when appropriate for continuous variables.
The median increment in total insulin requirement during pregnancy was based on each patient's change in insulin dose from before pregnancy until 33 weeks.
Statistically significant differences were defined as P , 0.05.
RESULTSdPatient characteristics are shown in Table 1 . The changes in total insulin requirement during twin pregnancy were as follows: a small increase from before pregnancy until 8 weeks, a decrease from 8 to 14 weeks, a substantial increase from 14 to 27 weeks, and from 27 to 33 weeks, the insulin requirement was almost stable (Table 1) .
Insulin requirements before pregnancy until 14 weeks were comparable in twin and singleton pregnancies. Between 14 and 27 weeks, the weekly increase in total insulin dose was higher in twin pregnancies compared with singleton pregnancies (3.0 The median increment in total insulin requirement during pregnancy tended to be higher in twin pregnancies compared with singleton pregnancies (a median increase of 103% [36-257%] versus 71% [220 to 276%]), giving a 45% higher increase in the twin pregnancies (P = 0.07).
If insulin requirement was expressed in IU per kilogram and not as total insulin dose, a similar pattern of changes was seen for both groups (data not shown).
HbA 1c was comparable throughout pregnancy in the two groups ( Table 1) .
The total placental weight was 74% higher in twin pregnancies (P , 0.0001). The total birth weight of twin pairs was 45% higher than that of singletons (Table 1) .
CONCLUSIONSdThis study documented a doubling of the weekly increase in total insulin requirement between 14 and 27 gestational weeks in twin pregnancies as compared with singleton pregnancies in women with type 1 diabetes.
The strength of this study is that the overall strategy of the insulin therapy in the patients was the same over the 11-year period and that a control group of singleton pregnancies with all clinical data including placental weight from the same large center was available. Despite a long inclusion period, a limited number of 15 cases of twin pregnancies were found. However, these data provide useful information for clinicians who are caring for these high-risk pregnancies, and a large prospective study on insulin therapy in twin pregnancies in diabetic women will probably not be performed.
At 14-27 weeks, a weekly increase in daily insulin dose of 3 IU was seen in the twin pregnancies. For singletons, the increase in this period was 1.5 IU in our study, which is comparable with previous findings of García-Patterson (3). These findings are certainly of clinical importance and probably associated with the growth of the larger total fetal and placental mass. From 27 to 33 weeks, the insulin requirement seemed rather stable compared with the continuous steady increase usually seen in singleton diabetic pregnancies (3) (4) (5) . This may be due to restricted placental and fetal growth often seen in twin pregnancies in late pregnancy and therefore a possible stagnation in the hormonal production. In twin pregnancies in healthy women, the individual twin grows at the same rate as a healthy singleton up until ;30-32 weeks (6,7). In the remaining part of pregnancy, a restricted growth rate is seen, probably because of reduced physical intrauterine space or uteroplacental insufficiency (8) .
The total increment of insulin dose was 45% higher in twin pregnancies compared with singleton pregnancies and not twice as much, corresponding well to the 45% higher fetal mass and 74% higher placental mass in these pregnancies.
In clinical use, pregnant women with type 1 diabetes expecting twins and their caregivers should be prepared for a possible decrease in insulin requirement in late first trimester, a weekly increase from 14 weeks, which is double as much as that seen in singleton pregnancies, Data are median (range) or n (%). CSII, continuous subcutaneous insulin infusions; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization. *Microalbuminuria: urine albumin excretions $30 mg/24 h; diabetic nephropathy: urine albumin excretions $300 mg/24 h based on two 24-h urine albumin excretions at inclusion. †n = 101. ‡Pre-eclampsia: either systolic blood pressure .140 mmHg or diastolic blood pressure .90 mmHg, and urinary albumin excretion .300 mg/24 h or $1+ on a sterile midstream urine dipstick after 20 weeks of gestation. xn = 43.
followed by a stable period from ;27 weeks.
